Galacto-oligosaccharides attenuate renal injury with microbiota modification

Physiological Reports

Volumn 2, Issue 7, 2014, Pages

  Furuse, Satoshi U ^a,b   Ohse, Takamoto ^a   Jo Watanabe, Airi ^a   Shigehisa, Akira ^c   Kawakami, Koji ^c   Matsuki, Takahiro ^c   Chonan, Osamu ^c   Nangaku, Masaomi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b MITSUI MEMORIAL HOSPITAL   (Japan)

^c YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

Author keywords

Endoplasmic reticulum stress; Galactooligosaccharides; Gut microbiota; Indoxyl sulfate; Kidney disease

Indexed keywords

CASPASE 3; CREATININE; GALACTOSE OLIGOSACCHARIDE; GLUCOSE REGULATED PROTEIN 78; INDICAN; INDOLE; MESSENGER RNA; SHORT CHAIN FATTY ACID; TRYPTOPHAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CLOSTRIDIACEAE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; FOOD INTAKE; IMMUNOHISTOCHEMISTRY; INTERSTITIAL NEPHRITIS; INTESTINE FLORA; KIDNEY FUNCTION; MACROPHAGE ACTIVATION; MALE; NEPHRECTOMY; NONHUMAN; PROTEIN URINE LEVEL; PYROSEQUENCING; RAT; REAL TIME POLYMERASE CHAIN REACTION; SYSTOLIC BLOOD PRESSURE; TUNEL ASSAY; UREA NITROGEN BLOOD LEVEL; WESTERN BLOTTING;

EID: 85002742046     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.14814/phy2.12029     Document Type: Article

References (34)

1. Caporaso, J. G., J. Kuczynski, J. Stombaugh, K. Bittinger, F. D. Bushman, E. K. Costello, et al. 2010. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7:335-336.
2. Clemente, J. C., L. K. Ursell, L. W. Parfrey, and R. Knight. 2012. The impact of the gut microbiota on human health: an integrative view. Cell 148:1258-1270.
3. Dicksved, J., J. Halfvarson, M. Rosenquist, G. Järnerot, C. Tysk, J. Apajalahti, et al. 2008. Molecular analysis of the gut microbiota of identical twins with Crohn’s disease. ISME J. 2:716-727.
4. Fuller, R. 1989. Probiotics in man and animals. J. Appl. Bacteriol. 66:365-378.
5. Gibson, G. R., and M. B. Roberfroid. 1995. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J. Nutr. 125: 1401-1412.
6. Hida, M., Y. Aiba, S. Sawamura, N. Suzuki, T. Satoh, and Y. Koga. 1996. Inhibition of the accumulation of uremic toxins in the blood and their precursors in the feces after oral administration of Lebenin, a lactic acid bacteria preparation, to uremic patients undergoing hemodialysis. Nephron 74:349-355.
7. Kawakami, T., R. Inagi, T. Wada, T. Tanaka, T. Fujita, and M. Nangaku. 2010. Indoxyl sulfate inhibits proliferation of human proximal tubular cells via endoplasmic reticulum stress. Am. J. Physiol. Renal Physiol. 299: F568-F576.
8. Kellow, N. J., M. T. Coughlan, and C. M. Reid. 2014. Metabolic benefits of dietary prebiotics in human subjects: a systematic review of dandomised controlled trials. Br. J. Nutr. 111:1147-1161.
9. Kikuchi, H., and T. Yajima. 1992. Correlation between water-holding capacity of different types of cellulose in vitro and gastrointestinal retention time in vivo of rats *. J. Sci. Food Agric. 60:139-146.
10. Kimura, K., K. Matsumoto, C. Ishihara, K. Harada, and A. Miyagi. 1995. Structure determination of galacto-oligosaccharides by pyridylamination and NMR spectroscopy. Carbohydr. Res. 270:33-42.
11. Ley, R. E., F. Bäckhed, P. Turnbaugh, C. A. Lozupone, R. D. Knight, and J. I. Gordon. 2005. Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. USA 102: 11070-11075.
12. Major, G., and R. Spiller. 2014. Irritable bowel syndrome, inflammatory bowel disease and the microbiome. Curr. Opin. Endocrinol. Diabetes Obes. 21:15-21.
13. Margulies, M., M. Egholm, W. E. Altman, S. Attiya, J. S. Bader, L. A. Bemben, et al. 2005. Genome sequencing in microfabricated high-density picolitre reactors. Nature 437:376-380.
14. Martinez, A. W., N. S. Recht, T. H. Hostetter, and T. W. Meyer. 2005. Removal of P-cresol sulfate by hemodialysis. J. Am. Soc. Nephrol. 16:3430-3436.
15. Matsumoto, M., T. Tanaka, T. Yamamoto, E. Noiri, T. Miyata, R. Inagi, et al. 2004. Hypoperfusion of peritubular capillaries induces chronic hypoxia before progression of tubulointerstitial injury in a progressive model of rat glomerulonephritis. J. Am. Soc. Nephrol. 15:1574-1581.
16. McBee, R. H. 1970. Metabolic contributions of the cecal flora. Am. J. Clin. Nutr. 23:1514-1518.
17. Meijers, B. K. I., V. De Preter, K. Verbeke, Y. Vanrenterghem, and P. Evenepoel. 2010. p-Cresyl sulfate serum concentrations in haemodialysis patients are reduced by the prebiotic oligofructose-enriched inulin. Nephrol. Dial. Transplant. 25:219-224.
18. Meyer, T. W., and T. H. Hostetter. 2007. Uremia. N. Engl. J. Med. 357:1316-1325.
19. Murdoch, D. A. 1998. Gram-positive anaerobic cocci. Clin. Microbiol. Rev. 11:81-120.
20. Nakabayashi, I., M. Nakamura, K. Kawakami, T. Ohta, I. Kato, K. Uchida, et al. 2011. Effects of synbiotic treatment on serum level of p-cresol in haemodialysis patients: a preliminary study. Nephrol. Dial. Transplant. 26:1094-1098.
21. Niwa, T. 2013. Targeting protein-bound uremic toxins in chronic kidney disease. Expert Opin. Ther. Targets 17: 1287-1301.
22. Ohse, T., M. R. Vaughan, J. B. Kopp, R. D. Krofft, C. B. Marshall, A. M. Chang, et al. 2010. De novo expression of podocyte proteins in parietal epithelial cells during experimental glomerular disease. Am. J. Physiol. Renal Physiol. 298:F702-F711.
23. Oyadomari, S., and M. Mori. 2004. Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ. 11: 381-389.
24. Palm, F., M. Nangaku, A. Fasching, T. Tanaka, L. Nordquist, P. Hansell, et al. 2010. Uremia induces abnormal oxygen consumption in tubules and aggravates chronic hypoxia of the kidney via oxidative stress. Am. J. Physiol. Renal Physiol. 299:F380-F386.
25. Qin, J., Y. Li, Z. Cai, S. Li, J. Zhu, F. Zhang, et al. 2012. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490:55-60.
26. Ramezani, A., and D. S. Raj. 2014. The gut microbiome, kidney disease, and targeted interventions. J. Am. Soc. Nephrol. 25:657-670.
27. Roberfroid, M., G. R. Gibson, L. Hoyles, A. L. McCartney, R. Rastall, I. Rowland, et al. 2010. Prebiotic effects: metabolic and health benefits. Br. J. Nutr. 104(Suppl.): S1-S63.
28. Round, J. L., and S. K. Mazmanian. 2009. The gut microbiota shapes intestinal immune responses during health and disease. Nat. Rev. Immunol. 9:313-323.
29. Savaiano, D. A., A. J. Ritter, T. R. Klaenhammer, G. M. James, A. T. Longcore, J. R. Chandler, et al. 2013. Improving lactose digestion and symptoms of lactose intolerance with a novel galacto-oligosaccharide (RP-G28): a randomized, double-blind clinical trial. Nutr. J. 12:160.
30. Shimizu, H., D. Bolati, A. Adijiang, G. Muteliefu, A. Enomoto, F. Nishijima, et al. 2011. NF-jB plays an important role in indoxyl sulfate-induced cellular senescence, fibrotic gene expression, and inhibition of proliferation in proximal tubular cells. Am. J. Physiol. Cell Physiol. 301:C1201-C1212.
31. Vaziri, N. D., J. Yuan, A. Rahimi, Z. Ni, H. Said, and V. S. Subramanian. 2012. Disintegration of colonic epithelial tight junction in uremia: a likely cause of CKD-associated inflammation. Nephrol. Dial. Transplant. 27:2686-2693.
32. Vaziri, N. D., J. Wong, M. Pahl, Y. M. Piceno, J. Yuan, T. Z. DeSantis, et al. 2013. Chronic kidney disease alters intestinal microbial flora. Kidney Int. 83:308-315.
33. Warren, Y. A., K. L. Tyrrell, D. M. Citron, and E. J. C. Goldstein. 2006. Clostridium aldenense sp. nov. and Clostridium citroniae sp. nov. isolated from human clinical infections. J. Clin. Microbiol. 44:2416-2422.
34. Wikoff, W. R., A. T. Anfora, J. Liu, P. G. Schultz, S. A. Lesley, E. C. Peters, et al. 2009. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc. Natl. Acad. Sci. USA 106:3698-3703.